DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
ANDEXANET ALFA
Search structure
Synonyms:
Andexanet alfa
Andexxa
PRT-064445
PRT064445
PRT-4445
rfXa Inhibitor Antidote
Status:
Phase 3
Entry Type:
Unknown
Molecule Category:
UNKNOWN
ATC:
V03AB38
UNII:
BI009E452R
Pharmacology
Action
Mechanism of Action
Reference
SEQUESTERING AGENT
Apixaban sequestering agent
FDA
EMA
Indications
Mesh Heading
Maximum Phase
Mesh ID
Reference
Hemorrhage
2
D006470
ClinicalTrials
Cross References
Resources
Reference
ChEMBL
CHEMBL3301583
FDA SRS
BI009E452R
CONTENTS
Structure
Indications
Cross References
×
Active Pharmaceutical Ingredients (APIs)
Scaffolds
Exact
Similarity
SubStructure
Threshold (%) >=
70